000 01285 a2200385 4500
005 20250515103426.0
264 0 _c20080519
008 200805s 0 0 eng d
022 _a0214-0934
040 _aNLM
_beng
_cNLM
100 1 _aLock, Ruth
245 0 0 _aEmerging therapies for respiratory diseases.
_h[electronic resource]
260 _bDrug news & perspectives
_cNov 2007
300 _a593-600 p.
_bdigital
500 _aPublication Type: Congress
650 0 4 _aAcetates
_xchemistry
650 0 4 _aAdrenal Cortex Hormones
_xtherapeutic use
650 0 4 _aAdrenergic beta-Agonists
_xtherapeutic use
650 0 4 _aAlbuterol
_xtherapeutic use
650 0 4 _aBudesonide
_xtherapeutic use
650 0 4 _aBudesonide, Formoterol Fumarate Drug Combination
650 0 4 _aCyclopropanes
650 0 4 _aDrug Combinations
650 0 4 _aDrug Therapy
_xmethods
650 0 4 _aEthanolamines
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLeukotriene Antagonists
_xchemistry
650 0 4 _aMolecular Structure
650 0 4 _aQuinolines
_xchemistry
650 0 4 _aRespiratory Tract Diseases
_xdrug therapy
650 0 4 _aSulfides
700 1 _aCollingwood, Steve
700 1 _aRatcliffe, Andrew
773 0 _tDrug news & perspectives
_gvol. 20
_gno. 9
_gp. 593-600
999 _c17686829
_d17686829